Investment firm EQT has taken a minority stake in SHL Medical which develops, and manufactures advanced drug delivery systems such as autoinjectors, pen injectors, and inhaler systems.
“We are impressed by SHL’s entrepreneurial spirit and the management team’s achievements in growing the firm into an industry leader with deep innovation and manufacturing capabilities,” said Andreas Aschenbrenner, partner at EQT Partners.
Headquartered in Switzerland with locations in Taiwan, Sweden and the US, SHL serves as a partner to global pharmaceutical companies and biotech firms. The company employs approximately 5,000 people worldwide.
In a statement EQT said that the investment is in line with its thematic approach and mindset of making a positive impact in society with everything it does, guided by the United Nations Sustainable Development Goals (SDGs).